[1]CurrentPatentAssignee:PUYERNANTONGBIOPHARMA-CN106349237,2017,A
[1]CurrentPatentAssignee:PUYERNANTONGBIOPHARMA-CN106349237,2017,A
[1]CurrentPatentAssignee:PUYERNANTONGBIOPHARMA-CN106349237,2017,A
[1]CurrentPatentAssignee:PUYERNANTONGBIOPHARMA-CN106349237,2017,A
[1]CurrentPatentAssignee:PUYERNANTONGBIOPHARMA-CN106349237,2017,A
Title: Fukuda-Tsuru S, et al. A novel, potent, and long-lasting dipeptidyl peptidase-4 inhibitor, teneligliptin, improves postprandial hyperglycemia and dyslipidemia after single and repeated administrations. Eur J Pharmacol. 2012 Dec 5;696(1-3):194-202.
Title: Ideta T, et al. The Dipeptidyl Peptidase-4 Inhibitor Teneligliptin Attenuates Hepatic Lipogenesis via AMPK Activation in Non-Alcoholic Fatty Liver Disease Model Mice. Int J Mol Sci. 2015 Dec 8;16(12):29207-18.